Dr. Daniel Furlong

Dr. Daniel Furlong
Dr. Furlong is a clinical associate within the Department of Urology at the Oregon Health & Science University (OHSU). Dr. Furlong and his partner, Dr. Koprowski, are proud to be the first Aquablation surgeons in the city of Portland. Dr. Furlong spearheaded the acquisition of Aquablation for OHSU Adventist Health Portland, which is now the first academic center in the Pacific Northwest offering this technology. Dr. Furlong graduated from the University of Southern California with a dual MD/MBA degree from Keck School of Medicine and Marshall School of Business. He then went on and completed his urologic surgery residency training in his hometown at the University of Miami/Jackson Memorial Hospital in Miami, Florida. He subsequently pursued advanced fellowship training at the Medical University of South Carolina, specializing in female pelvic medicine, male and female urologic reconstruction, neurourology and complex voiding dysfunction. He strives to continuously adopt the latest evidence-based emerging techniques, treatments and technologies into his practice, and is passionate about offering Aquablation to his patients.
Medical School:

Keck School of Medicine of University of Southern California

Residency:

University of Miami

Fellowship:

Medical University of South Carolina

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only